Ketorolac is generally stronger than tramadol for acute pain relief. In head-to-head clinical trials, patients given 10 mg of oral ketorolac reported less pain, needed fewer additional painkillers, and went longer before requesting more medication compared to those given 50 mg of tramadol. In one post-surgical study, 73% of patients in the ketorolac group rated their pain relief as “good,” compared to just 27% in the tramadol group.
How They Compare in Clinical Trials
The most direct comparisons come from dental surgery studies, where researchers can standardize the procedure and measure pain on a consistent scale. In a trial published in Medicina Oral, Patología Oral y Cirugía Bucal, patients who took 10 mg of oral ketorolac before wisdom tooth removal had significantly lower pain scores at the third and fourth postoperative hours than patients who received 50 mg of intramuscular tramadol. That’s a notable result: an oral pill outperformed an injected dose of the competing drug.
A separate trial published in the National Journal of Maxillofacial Surgery compared 30 mg of intravenous ketorolac to 50 mg of intravenous tramadol. Throughout a six-hour observation window, the ketorolac group reported lower pain intensity, used fewer rescue painkillers, and gave higher scores on a global assessment of their treatment. Ketorolac consistently came out ahead on nearly every pain measure.
Ketorolac Lasts Longer, Tramadol Acts Faster
One area where tramadol does win is speed. In the IV comparison, tramadol’s average onset of relief was about 3 minutes, while ketorolac took closer to 14 minutes. That initial gap is real, but it reverses quickly. Ketorolac’s pain relief lasted an average of 9.5 hours, more than double tramadol’s 4 hours. So ketorolac is slower to kick in but provides substantially longer coverage per dose.
Why They Work So Differently
These two drugs attack pain through completely different pathways, which is part of why their effects feel different.
Ketorolac is a powerful NSAID (in the same family as ibuprofen, but much stronger). It works by blocking the enzymes that produce prostaglandins, the chemicals your body releases at an injury site that amplify pain and trigger inflammation. By shutting down prostaglandin production, ketorolac reduces both the pain signal and the swelling driving it. This makes it especially effective for pain that involves tissue inflammation, like surgical recovery, kidney stones, or dental procedures.
Tramadol takes a two-pronged approach in the brain. It weakly activates opioid receptors (the same targets that morphine hits, but with far less strength) and it also increases levels of serotonin and norepinephrine, two brain chemicals involved in dampening pain signals from above. This dual mechanism makes tramadol useful for moderate pain, but the opioid component is genuinely weak. The body actually converts tramadol into a more active compound that is two to four times more potent than the original drug, and that metabolite does much of the heavy lifting.
Because tramadol doesn’t affect prostaglandins, it has no anti-inflammatory effect. For pain driven by swelling and tissue damage, that’s a meaningful disadvantage.
Side Effects Worth Knowing
The side effect profiles are almost completely different, reflecting their separate mechanisms.
Ketorolac’s biggest risks involve the stomach, kidneys, and cardiovascular system. It can cause stomach ulcers, gastrointestinal bleeding, and, in rare cases, perforation of the stomach or intestinal wall. These events can happen without warning symptoms. It also poses risks for people with kidney problems, since it can impair kidney function, particularly in anyone who is dehydrated. There’s an additional cardiovascular concern: like other NSAIDs, it may increase the risk of heart attack and stroke, with that risk climbing the longer you use it.
Tramadol’s risks lean toward the brain and nervous system. Drowsiness, dizziness, and nausea are common. Because it boosts serotonin levels, combining tramadol with antidepressants or other serotonin-raising medications can trigger serotonin syndrome, a potentially dangerous condition involving agitation, rapid heart rate, high body temperature, and muscle rigidity. Tramadol also carries a risk of dependence and withdrawal with prolonged use, since it activates opioid receptors. Seizures are another known risk, especially at higher doses.
Ketorolac Has a Strict Time Limit
One of ketorolac’s defining features is that you can’t take it for long. The FDA limits total use to five days, whether by injection, pill, or a combination of both. That limit exists because the risk of serious gastrointestinal and kidney complications climbs sharply with extended use. This makes ketorolac a short-term tool for acute pain, not something you can take for weeks.
Tramadol doesn’t carry the same hard time limit and is sometimes prescribed for longer-term pain management. However, the trade-off is the potential for physical dependence. Stopping tramadol abruptly after regular use can cause withdrawal symptoms.
Which One Is Better for Your Situation
For short-term, acute pain with an inflammatory component, ketorolac is typically the stronger and more effective option. Post-surgical pain, dental pain, and kidney stone pain are classic scenarios where ketorolac excels. Its combination of potent pain relief and anti-inflammatory action addresses the root cause of the pain, not just the perception of it.
Tramadol may be preferred when NSAIDs are off the table. If you have a history of stomach ulcers, kidney disease, or bleeding disorders, ketorolac is likely contraindicated. Tramadol is also an option when pain management needs to extend beyond five days, or when the pain is less inflammatory in nature. For people already taking blood thinners or those at high cardiovascular risk, tramadol avoids some of ketorolac’s most concerning interactions.
In terms of raw analgesic strength for acute pain, though, the clinical evidence consistently favors ketorolac. It provides deeper pain relief, longer duration per dose, and higher patient satisfaction ratings in direct comparisons.